Related Experiment Video
Updated: Aug 21, 2025

Extraction and Purification of FAHD1 Protein from Swine Kidney and Mouse Liver
Published on: February 18, 2022
Comparison of four medium cut-off dialyzers
Francisco Maduell1, José Jesús Broseta1, Diana Rodríguez-Espinosa1
1Department of Nephrology, Hospital Clínic Barcelona, Barcelona, Spain.
Background:
Recently, several pharmaceutical companies have developed new medium cut-off (MCO) dialyzers for expanded hemodialysis (HDx). This study aimed to compare the safety and efficacy of four MCO dialyzers, against each other and versus high-flux hemodialysis (HD) and post-dilution hemodiafiltration (HDF).
Methods:
A prospective study was carried out on 23 patients who underwent six dialysis sessions: two sessions with the FX80 Cordiax in HD and HDF, and four HDx sessions with the Phylther 17-SD, Vie-18X, Elisio HX19 and Theranova 400 dialyzers. The reduction ratios (RRs) of urea, creatinine, β2-microglobulin, myoglobin, kappa free immunoglobulin light chain (κFLC), prolactin, α1-microglobulin, α1-acid glycoprotein, lambda (λFLC) and albumin were compared. Dialysate albumin loss was also measured.
Results:
The differences in efficacy between the evaluated dialyzers were minimal in small molecules and even up to the size of β2-microglobulin. The main differences were found between myoglobin, κFLC, prolactin, α1-microglobulin and λFLC RRs, in which all four MCO dialyzers, with similar efficacy, were clearly superior to HD and slightly inferior to HDF treatment. Albumin losses in the dialysate with HD dialyzers were <1 g and between 1.5 and 2.5 g in HDx and HDF. The global removal score values were similar in all four HDx treatments, and again significantly higher than those with HD.
Conclusions:
The results of the four MCO dialyzers evaluated in this study showed good efficiency, with no significant performance differences between them while being completely safe in terms of albumin loss. Likewise, the study confirms the superiority of HDx over high-flux HD with an efficacy close to that of post-dilution HDF.
Insights
Four new medium cut-off (MCO) dialyzers show comparable safety and efficacy for expanded hemodialysis (HDx), outperforming standard hemodialysis (HD) and nearing hemodiafiltration (HDF) performance.
Area of Science:
- Nephrology
- Biomedical Engineering
- Medical Devices
Background:
- New medium cut-off (MCO) dialyzers have been developed for expanded hemodialysis (HDx).
- Comparison of these MCO dialyzers against each other and against high-flux hemodialysis (HD) and post-dilution hemodiafiltration (HDF) is crucial.
Purpose of the Study:
- To compare the safety and efficacy of four novel MCO dialyzers.
- To evaluate their performance against conventional high-flux HD and HDF treatments.
Main Methods:
- A prospective study involving 23 patients undergoing six dialysis sessions.
- Inclusion of FX80 Cordiax (HD and HDF) and four MCO dialyzers (Phylther 17-SD, Vie-18X, Elisio HX19, Theranova 400) for HDx.
- Measurement of reduction ratios for various solutes and assessment of dialysate albumin loss.
Main Results:
- Minimal efficacy differences among MCO dialyzers for small molecules and β2-microglobulin.
- MCO dialyzers showed superior reduction ratios for larger solutes (myoglobin, κFLC, prolactin, α1-microglobulin, λFLC) compared to HD, and were slightly inferior to HDF.
- Albumin loss was minimal (<1 g) with HD, moderate (1.5–2.5 g) with HDx and HDF.
Conclusions:
- The four evaluated MCO dialyzers demonstrate good efficiency and safety, with no significant performance variations among them.
- Expanded hemodialysis (HDx) using MCO dialyzers is superior to high-flux HD and approaches the efficacy of post-dilution HDF.
Related Concept Videos
Dialysis
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

